0 citations
Amifostine Used as a Normal Tissue Protectant in Patients Receiving Pelvic Radiotherapy
International Journal of Radiation Oncology*Biology*Physics2005Vol. 63, pp. S448–S448
Citations Over Time
Related Papers
- Narrow amifostine dose windows define radioprotection outcome, following fractionated whole-body irradiation of mice.(2011)
- Future development of amifostine as a radioprotectant.(1999)
- → Cytoprotection in Chemo – and Radiotherapy with Amifostine (Ethyol): A New Strategy in Oncology(1996)2 cited
- [Ethyol (amifostine): application trial in pediatric oncology].(1998)
- → Amifostine(2007)